July 23, 2014
Singulex Highlights Development Progress With Ultrasensitive Sgx ClarityTM System at AACC 2014
May 21, 2014
Singulex Appoints Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer
Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.
Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.